Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Claus

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Cancers|October 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA ConsortiumFlorian Lüke, Florian Haller, Kirsten Utpatel, et al.
Blood Advances|July 1, 2021
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomasNora Liebers, Johannes Duell, Donnacha Fitzgerald, et al.
Nature Communications|December 21, 2017
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemiaDaniel B Lipka, Tania Witte, Reka Toth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
Breast Cancer Research and Treatment|December 1, 2010
Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Rainer Claus, Lucie Dostal, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Cancers|October 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA ConsortiumFlorian Lüke, Florian Haller, Kirsten Utpatel, et al.
Blood Advances|July 1, 2021
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomasNora Liebers, Johannes Duell, Donnacha Fitzgerald, et al.
Nature Communications|December 21, 2017
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemiaDaniel B Lipka, Tania Witte, Reka Toth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of GermanyMarkus Krebs, Florian Haller, Silvia Spörl, et al.
Breast Cancer Research and Treatment|December 1, 2010
Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Rainer Claus, Lucie Dostal, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Pageof 13